Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|December 20, 2021
FcER1: A Novel Molecule Implicated in the Progression of Human Diabetic Kidney DiseaseSwastika Sur, Mark Nguyen, Patrick Boada, et al.
BMC Bioinformatics|November 4, 2010
Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplantsAlexander A Morgan, Purvesh Khatri, Richard Hayden Jones, et al.
Plos One|February 26, 2013
Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrateSilke Roedder, Naoyuki Kimura, Homare Okamura, et al.
Pediatric Transplantation|November 13, 2008
Combined liver-kidney transplantation in children: indications and outcomeScott M Sutherland, Steven R Alexander, Minnie M Sarwal, et al.
Pediatric Nephrology (Berlin, Germany)|September 17, 2011
Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndromeAditi Sinha, Arvind Bagga, Ashima Gulati, et al.
Pediatric Nephrology (Berlin, Germany)|January 28, 2026
Fibrocystin/polyductin (FPC): new functional insights into ARPKD pathogenesis revealed by informatics, comparative genomics, and model systemsAshima Gulati, Ljubica Caldovic, Lisa M Guay-Woodford
Frontiers in Immunology|February 7, 2018
Corrigendum: Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney TransplantSilvia Pineda, Tara K Sigdel, Jieming Chen, et al.
Frontiers in Immunology|December 21, 2017
Novel Non-Histocompatibility Antigen Mismatched Variants Improve the Ability to Predict Antibody-Mediated Rejection Risk in Kidney TransplantSilvia Pineda, Tara K Sigdel, Jieming Chen, et al.
Molecular & Cellular Proteomics : MCP|December 25, 2010
Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal diseaseAtul J Butte, Tara K Sigdel, Persis P Wadia, et al.
Transplantation|November 25, 2003
Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantationMinnie M Sarwal, Jayakumar R Vidhun, Steven R Alexander, et al.
Pageof 21